Proper Name: Alpha1-Proteinase Inhibitor (Human)
Manufacturer: Talecris Biotherapeutics, Inc. License #1716
- indicated for chronic replacement therapy of individuals having congenital deficiency of alpha -antitrypsin deficiency with clinically demonstrable panacinar emphysema.
- FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.